These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7870369)

  • 1. Resistance to rHuEpo and kidney graft rejection.
    Page B; Zingraff J
    Nephrol Dial Transplant; 1994; 9(11):1696. PubMed ID: 7870369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of recombinant human erythropoietin therapy on renal transplantation.
    Ettenger RB; Marik J; Grimm P
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):57-61. PubMed ID: 1928081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin and renal transplantation.
    Muirhead N
    Kidney Int Suppl; 1999 Mar; 69():S86-92. PubMed ID: 10084292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
    Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
    Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resistance to rHuEPO].
    Sułowicz W
    Przegl Lek; 1995; 52(3):88-9. PubMed ID: 7644681
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythropoietin].
    Uhl D
    Med Monatsschr Pharm; 1990 May; 13(5):130-1. PubMed ID: 2192242
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of erythropoietin resistance with cyclosporin.
    Almond MK; Tailor D; Kelsey SM; Cunningham J
    Lancet; 1994 Apr; 343(8902):916-7. PubMed ID: 7908376
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 10. [The significance of erythropoietin for nephrology].
    Watzinger U; Peer G; Barnas U; Mayer G; Luger A; Kovarik J; Graf H
    Wien Klin Wochenschr; 1990 Mar; 102(5):125-30. PubMed ID: 2181782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
    Grimm PC; Sekiya NM; Robertson LS; Robinson BJ; Ettenger RB
    Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy.
    Goicoechea M; Gomez-Campdera F; Polo JR; Tejedor A; Ruiz MA; Vazquez I; Verde E; Valderrabano F
    Clin Nephrol; 1996 Jun; 45(6):420-1. PubMed ID: 8793241
    [No Abstract]   [Full Text] [Related]  

  • 13. rHuEpo-resistant anaemia in haemodialysis patients.
    Ozono Y; Harada T; Taura K; Kawatomi M; Hara K
    Nephrol Dial Transplant; 1994; 9(7):872-4. PubMed ID: 7970133
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Causes of anemia after kidney transplantation].
    Lezaić V; Djukanović Lj; Biljanović-Paunović L
    Srp Arh Celok Lek; 1994; 122(9-10):276-80. PubMed ID: 17977435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythropoietin resistance in the treatment of the anemia of chronic renal failure.
    Priyadarshi A; Shapiro JI
    Semin Dial; 2006; 19(4):273-8. PubMed ID: 16893403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity.
    Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ
    Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of cyclosporine rescue therapy in steroid resistant rejections.
    Sharma RK; Elhence R; Kher V; Gupta A; Kumar A; Bhandari M; Agrawal S
    Transplant Proc; 1994 Oct; 26(5):2556-7. PubMed ID: 7940789
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.